27 - 28 March 2025, Brussels, Belgium

The OMCL Gene Therapy Working Group held its latest meeting from 27 to 28 March 2025 hosted by Sciensano at their premises in Brussels, Belgium. The two-day event brought together members of the group to foster collaboration and knowledge exchange and welcomed five external experts for an open session for exchange on the latest technologies and challenges.

The group members participated in closed working sessions focused on ongoing studies, with AAV vector analysis remaining the central topic. Discussions also explored opportunities to broaden the scope to include other vector systems, alongside strategic planning for upcoming initiatives and future projects. Building laboratory capacities remained a key priority throughout. 

The open session featured five invited speakers who shared valuable insights on recent data, market tendencies, and challenges faced across the field. These interactions helped spark ideas for future collaboration and brought fresh perspectives into the group’s work. 

Beyond the formal discussions, the event offered an opportunity for networking and informal exchange in a warm and collegial atmosphere, encouraging valuable connections and synergy.